Design, Synthesis, and Antitumor Activity of Novel 5-Pyridyl-1,3,4- oxadiazole Derivatives against the Breast Cancer Cell Line MCF-7
Date
2015
Journal Title
Journal ISSN
Volume Title
Type
Article
Publisher
Biol. Pharm. Bull
Series Info
Biol. Pharm. Bull;Vol. 38, No. 5
Scientific Journal Rankings
Abstract
Various 1,3,4-oxadiazole-2-thiol derivatives have considerable potential in the field of antitumor activity.
On the basis of the structure of the highly active reported oxadiazole analogues, 36 novel compounds were
designed. Their molecular transport properties were predicted using a computer-aided program, and they
were then synthesized and tested for anticancer activity against the breast cancer cell line MCF-7. Most of
the tested compounds showed excellent to potent cytotoxic activity. Docking studies were carried out to examine
the possibilities of the target compounds to become lead compounds in the future after more biological
investigations. Compounds 18 and 22 were more active than the reference drug with IC50 values of 0.010 μM
and 0.012 μM, respectively, and binding energy scores of 10.32 and 10.25, respectively.
Description
Keywords
oxadiazole, synthesis, cytotoxic activity, pharmacokinetic parameter, docking study
Citation
1) Sun J, Zhu H, Yang Z-M, Zhu H-L. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4- oxadiazole-2(3H)-thionequinolone-derivatives as novel anticancer agent. Eur. J. Med. Chem., 60, 23–28 (2013). 2) Zhang L-R, Liu Z-J, Zhang H, Sun J, Luo Y, Zhao T-T, Gong H-B, Zhu H-L. Synthesis, biological evaluation and molecular docking studies of novel 2-(1,3,4-oxadiazol-2-ylthio)-1-phenylethanone derivatives. Bioorg. Med. Chem., 20, 3615–3621 (2012). 3) Zhang X-M, Qiu M, Sun J, Zhang Y-B, Yang Y-S, Wang X-L, Tang J-F, Zhu H-L. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents. Bioorg. Med. Chem., 19, 6518–6524 (2011). 4) Zheng Q-Z, Zhang X-M, Xu Y, Cheng K, Jiao Q-C, Zhu H-L. Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety as potential antitumor agents. Bioorg. Med. Chem., 18, 7836–7841 (2010). 5) Akhtar T, Hameed S, Al-Masoudi N, Loddo R, Colla P. In vitro antitumor and antiviral activities of new benzothiazole and 1,3,4-oxadiazole-2-thione derivatives. Acta Pharm., 58, 135–149 (2008). 6) Saeed A. An expeditious, solvent-free synthesis of some 5-aryl- 2-(2-hydroxyphenyl)-1,3,4-oxadiazoles. Chem. Heterocylc. Copds., 43, 1072–1075 (2007). 7) Aboraia AS, Abdel-Rahman HM, Mahfouz NM, El-Gendy MA. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole- 2-thione derivatives: Promising anticancer agents. Bioorg. Med. Chem., 14, 1236–1246 (2006). 8) Guimarães CRW, Boger DL, Jorgensen WL. Elucidation of fatty acid amide hydrolase inhibition by potent α-ketoheterocycle derivatives from Monte Carlo simulations. J. Am. Chem. Soc., 127, 17377–17384 (2005). 9) Zheng L, Wang X, China PR, Wang X. Syntheses and biological activities of 2-(3-methylbenzoylamino)-5-aryloxymethyl-1,3,4-oxadiazoles. Indian J. Chem., 42B, 941 (2003). 10) Wang H-H, Qiu K-M, Cui H-E, Yang Y-S, Yin-Luo, Xing M, Qiu X-Y, Bai L-F, Zhu H-L. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives containing benzodioxole as potential anticancer agents. Bioorg. Med. Chem., 21, 448–455 (2013). 11) Liu K, Lu X, Zhang H-J, Sun J, Zhu H-L. Synthesis, molecular modeling and biological evaluation of 2-(benzylthio)-5-aryloxadiazole derivatives as anti-tumor agents. Eur. J. Med. Chem., 47, 473–478 (2012). 12) Jha KK, Samad A, Kumar Y, Shaharyar M, Khosa RL, Jain J, Kumar V, Singh P. Design, synthesis and biological evaluation of 1,3,4-oxadiazole derivatives. Eur. J. Med. Chem., 45, 4963–4967 (2010). 13) Ertl P, Rohde B, Selzer P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J. Med. Chem., 43, 3714–3717 (2000). 14) Alegaon SG, Alagawadi KR, Sonkusare PV, Chaudhary SM, Dadwe DH, Shah AS. Novel imidazo[2,1-b][1,3,4]thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents. Bioorg. Med. Chem. Lett., 22, 1917–1921 (2012). 15) Lipinski CA, Lombardo L, Dominy BW, Feeney P. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev., 46, 3–26 (2001). 16) de Oliveira CS, Lira BF, dos Santos Falcão-Silva V, Siqueira-Junior JP, Barbosa-Filho JM, de Athayde-Filho PF. Synthesis, molecular properties prediction, and anti-staphylococcal activity of nacylhydrazones and new 1,3,4-oxadiazole derivatives. Molecules, 17, 5095–5107 (2012). 17) Bakht MA, Yar MS, Abdel-Hamid SG, Al Qasoumi SI, Samad A. Molecular properties prediction, synthesis and antimicrobial activity of some newer oxadiazole derivatives. Eur. J. Med. Chem., 45, 5862–5869 (2010). 18) Veber DF, Johnson SR, Cheng H-Y, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidate. J. Med. Chem., 45, 2615–2623 (2002). 19) El-Sayed WA, Hegab MIH, Tolan EM, Abdel-Rahman AA-H. Synthesis and characterization of mono- and bicyclic heterocyclic derivatives containing 1,2,4-triazole, 1,3,4-thia-, and oxadiazole rings. Monatsh. Chem., 139, 1055–1060 (2008). 20) Daoud KM, Ismaeel SS, Al-Jawharji YS. Conversion of substituted thiosemicarbazide and 1,3,4-oxadiazole to 5-substituted/4,5-disubstituted- 1,2,4-triazole-3-thiol. College of Basic Edu. Res. J., 4, 348 (2007). 21) Koparır M, Çetin A, Cansız A. 5-Furan-2yl[1,3,4]oxadiazole-2-thiol, 5-furan-2yl-4H[1,2,4]triazole-3-thiol and their thiol-thione tautomerism. Molecules, 10, 475–480 (2005). 22) Guo-qiang H, Qiu-ju X, Bao L, Zhong-quan Z, Bai-quan C, Qi-tai X, Wen-long H, Hui-bin Z, Sheng-tang H. Targets and studies on anti-SARS drugs. Acta Pharmacol. Sin., 39, 263 (2004). 23) Bayrak H, Demirbas A, Karaoglu SA, Demirbas N. Synthesis of some new 1,2,4-triazoles, their Mannich and Schiff bases and evaluation of their antimicrobial activities. Eur. J. Med. Chem., 44, 1057–1066 (2009). 24) Mobinikhaledi A, Foroughifar N, Khanpour M, Ebrahimi S. Synthesis of some novel Schiff bases containing 1,2,4-triazole ring. Eur. J. Chem., 1, 33–36 (2010). 25) Monk A, Scudiero DA, Skehan P, Shoemaker RH, Paull KD. DTP, DCTD Tumor repository a catalog of in vitro cell lines, transplantable animal and human tumors and micro assays. J. Natl. Cancer Inst., 83, 757 (1991). 26) El-Emary TI, Abd El-Mohsen SA. Multi-component one-pot synthesis and antimicrobial activities of 3-methyl-1,4-diphenyl-7-thioxo- 4,6,8,9-tetrahydropyrazolo[5,4-b]pyrimidino[5,4-e]pyridine-5-one and related derivatives. Molecules, 17, 14464–14483 (2012). 27) Mir I, Siddiqui MT, Comrie AM. Synthesis of α-[5-(2-, 3-, and 4-pyridyl)1,3,4-oxadiazol-2-ylthio]acetohydrazide